A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
Clinical trial NCT06658834 · RECRUITING
Trial details
- NCT number
- NCT06658834
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-06-30
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.